{
    "title": "Valeant steps in to work on psoriasis drug with AstraZeneca",
    "url": "https://www.dailymail.co.uk/wires/ap/article-3218932/Valeant-steps-work-psoriasis-drug-AstraZeneca.html",
    "date": "2015-09-01",
    "keywords": [
        "drug",
        "psoriasis",
        "amgen",
        "brodalumab",
        "valeant",
        "treatment",
        "depression",
        "astrazeneca",
        "gmt",
        "september",
        "disease",
        "press",
        "york",
        "ap",
        "drugmaker",
        "competitor",
        "biotech",
        "giant",
        "research",
        "link",
        "behaviorvaleant",
        "share",
        "drugthe",
        "tuesday",
        "approval",
        "union",
        "quarter",
        "market",
        "condition",
        "immune",
        "system",
        "growth",
        "cycle",
        "cellskyowa",
        "hakko",
        "co",
        "japan",
        "asiabrodalumab",
        "receptor",
        "body",
        "block",
        "cosentyx",
        "sale",
        "year",
        "way",
        "work",
        "behavior",
        "use",
        "statement",
        "safety",
        "effectiveness",
        "biggestselling",
        "injection",
        "food",
        "administration",
        "tablet",
        "otezla",
        "history",
        "side",
        "inc",
        "percent",
        "plc",
        "antibody",
        "partnership"
    ],
    "category": [
        "wires",
        "ap"
    ]
}